Evidence map›Paper›PMID 37088992›Full record

ArticleCell cycle (Georgetown, Tex.)2023

METTL3 affects FLT3-ITD+ acute myeloid leukemia by mediating autophagy by regulating PSMA3-AS1 stability.

Shenghao Wu, Shanshan Weng, Wenjin Zhou, Yuemiao Chen, Zhen Liu

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Methyltransferase-like 3-mediated RNA NFrontiers in immunology · 2025
    Review
  4. Autophagy: a critical mechanism of NCell death & disease · 2024
    Review
  5. Small molecule inhibitors targeting mJournal of hematology & oncology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Shenghao WuDepartment of Hematology, The Dingli Clinical Institute of Wenzhou Medical University (The Second Affiliated Hospital of Shanghai University , Wenzhou Central Hospital), Wenzhou, Zhejiang Province, China.
Shanshan WengDepartment of Hematology, The Dingli Clinical Institute of Wenzhou Medical University (The Second Affiliated Hospital of Shanghai University , Wenzhou Central Hospital), Wenzhou, Zhejiang Province, China.
Wenjin ZhouDepartment of Hematology, The Dingli Clinical Institute of Wenzhou Medical University (The Second Affiliated Hospital of Shanghai University , Wenzhou Central Hospital), Wenzhou, Zhejiang Province, China.
Yuemiao ChenDepartment of Hematology, The Dingli Clinical Institute of Wenzhou Medical University (The Second Affiliated Hospital of Shanghai University , Wenzhou Central Hospital), Wenzhou, Zhejiang Province, China.
Zhen LiuDepartment of Hematology, The Dingli Clinical Institute of Wenzhou Medical University (The Second Affiliated Hospital of Shanghai University , Wenzhou Central Hospital), Wenzhou, Zhejiang Province, China.
Wenzhou Medical University · CNWenzhou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study was designed to explore the role of PSMA3-AS1 in initiation and progression of acute myeloid leukemia (AML) and investigate its action mechanism. Expression of PSMA3-AS1, miR-20a-5p and ATG16L1 both

Indexed as

Leukemia, Myeloid, AcuteMicroRNAsApoptosisAutophagyCell Line, TumorCell Proliferationfms-Like Tyrosine Kinase 3HumansMethyltransferasesProteasome Endopeptidase ComplexRNA, MessengerFLT3 protein, humanfms-Like Tyrosine Kinase 3MethyltransferasesMETTL3 protein, humanMicroRNAsProteasome Endopeptidase ComplexPSMA3 protein, humanRNA, MessengerAcute myeloid leukemia (AML)autophagyFLT3-ITDN6-methyladenosinePSMA3-AS1

Identifiers

PMID37088992
PMCPMC10193868
OpenAlexW4366822620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.